Filing Details

Accession Number:
0001179110-16-031973
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-22 17:45:43
Reporting Period:
2016-11-20
Filing Date:
2016-11-22
Accepted Time:
2016-11-22 17:45:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080014 Innoviva Inc. INVA Pharmaceutical Preparations (2834) 943265960
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1622268 Eric Desparbes 2000 Sierra Point Parkway
Suite 500
Brisbane CA 94005
Svp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-11-20 3,832 $10.91 233,127 No 4 F Direct
Common Stock Disposition 2016-11-21 1,800 $10.89 231,327 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.
  2. Includes 766 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on November 15, 2016.
  3. This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated May 20, 2016.